Luma Fertility Raises $4M to Redesign India’s Fertility Care
- Alice Tooley
- Jul 9
- 2 min read

Luma Fertility, a Mumbai-based start-up founded by Neha K. Motwani, has raised $4 million in seed funding to grow its patient-first fertility services across India. The funding round was led by Peak XV’s Surge and included investors like Ameera Shah of Metropolis Healthcare and Vijay Taparia of B2V Ventures.
Born from Personal Experience
Motwani founded Luma after navigating her own fertility journey.
“In my own experience and after speaking to hundreds of women, it became clear that fertility care in India is broken. It’s optimised for systems, not people,” she said. “At Luma, we’ve rebuilt it entirely around the patient.”
A Tech-Forward Approach
Luma operates a 6,000 sq. ft. flagship clinic in Mumbai, one of India’s largest and most advanced fertility centres. The facility includes a state-of-the-art lab with in-house capabilities for IVF, egg and embryo freezing, and fertility assessments. It also features India’s first integrated IVF app, a see-through embryology lab, and AI-based tools like “LumaAI” for patient support.
Holistic, Personalised Care
Every Luma patient is assigned a dedicated care specialist. The clinic also offers at-home semen analysis, emotional support, IV drips, nutrition, and acupuncture.
“Fertility care in India is at an inflection point,” said Ameera Shah. “What drew me to Luma is their full-stack, customer-first approach.”
Looking Ahead
The company plans to expand further across Mumbai and into new cities over the next two years.
“There is a clear need for consumer-first healthcare in India, especially in verticals like fertility,” said Vijay Taparia. “Luma’s patient-first, outcome-driven approach paves the way for better care.”
Meeting Market Demand
India’s fertility market is expanding as more people seek options amid rising awareness and delayed family planning. Luma’s combination of traditional fertility treatments, digital tools, and holistic care positions it to lead a new generation of reproductive healthcare.




Comments